Half of patients who could benefit from genetic cancer testing are missing out due to ‘complicated’ NHS rules, a new study suggests.
Experts from the Institute of Cancer Research (ICR) have said NHS should widen out its guidelines on which patients can receive tests that can detect genetic mutations linked to cancer, after a study found half of patients carrying “harmful” genes would have missed out on testing.
